Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1991-2-14
pubmed:abstractText
Two different mutations in the c-erbA beta thyroid hormone receptor have recently been reported as genetic abnormalities responsible for the syndrome of generalized thyroid hormone resistance (GTHR). We have now found in a third kindred, D, in which GTHR is inherited as a dominant disease, a new point mutation in the T3-binding domain of c-erbA beta. A guanine to cytosine base substitution at nucleotide position 1305, which altered codon-335 from glutamine (CAG) to histidine (CAC), was found in one allele of 10 affected members and was not found in 6 unaffected members. This C-1305 sequence was not present in 106 random alleles, indicating that it was a mutation in c-erbA beta, and it was tightly linked to GTHR in kindred D, with a maximum logarithm of the odds score of 4.19 at a recombination fraction of 0. The tight linkage result confirms that GTHR maps to the c-erbA beta locus in multiple kindreds. In view of the tight linkage between the C-1305 mutation and GTHR, and that this mutation is a nonconservative alteration in a crucial region of the T3-binding domain, it is probably the genetic defect in kindred D responsible for GTHR. The kindred D receptor appears to result in a different phenotype of tissue resistance compared to the previously reported kindred. A receptor with a mutation in the carboxy-terminus of c-erbA beta.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-972X
pubmed:author
pubmed:issnType
Print
pubmed:volume
72
pubmed:geneSymbol
c-erbA&bgr;
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32-8
pubmed:dateRevised
2008-8-19
pubmed:meshHeading
pubmed-meshheading:1846005-Base Sequence, pubmed-meshheading:1846005-Binding Sites, pubmed-meshheading:1846005-Cytosine, pubmed-meshheading:1846005-Deoxyribonucleases, Type II Site-Specific, pubmed-meshheading:1846005-Drug Resistance, pubmed-meshheading:1846005-Endocrine System Diseases, pubmed-meshheading:1846005-Female, pubmed-meshheading:1846005-Humans, pubmed-meshheading:1846005-Lod Score, pubmed-meshheading:1846005-Male, pubmed-meshheading:1846005-Molecular Sequence Data, pubmed-meshheading:1846005-Mutation, pubmed-meshheading:1846005-Pedigree, pubmed-meshheading:1846005-Pituitary Gland, pubmed-meshheading:1846005-Proto-Oncogene Proteins, pubmed-meshheading:1846005-Receptors, Thyroid Hormone, pubmed-meshheading:1846005-Syndrome, pubmed-meshheading:1846005-Thyroid Hormones, pubmed-meshheading:1846005-Thyrotropin-Releasing Hormone, pubmed-meshheading:1846005-Triiodothyronine
pubmed:year
1991
pubmed:articleTitle
A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.
pubmed:affiliation
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858-4354.
pubmed:publicationType
Journal Article